跳至主要内容
临床试验/NCT06370442
NCT06370442尚未招募3 期

Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult

State University of New York - Upstate Medical University0 个研究点目标入组 60 人开始时间: 2024年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
主要终点
Sedation

研究概览

简要总结

The purpose of the study is to determine if intranasal dexmedetomidine could be an alternative to the current standard of care (injectable benzodiazepines or antipsychotics) for sedation prior to computerized tomography (CT) or magnetic resonance imaging (MRI) in those greater than or equal to 65 years of age (older adults) that are seen in the Emergency Department (ED).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • 65 years of age and older
  • Patients in need of sedation prior to either a computerized tomography (CT) or magnetic resonance imaging (MRI)

排除标准

  • Patients who weigh < 50 kg
  • Cardiac arrhythmias or QTc >450
  • Intravenous access not standard of care or unable to obtain
  • Patients with any allergies or contraindications to dexmedetomidine, haloperidol (i.e. patients diagnosed with Parkinson's) or lorazepam
  • Patients with low blood pressure, defined as a less than 100/60 mmHg
  • Patients with bradycardia (Heart rate < 60 bpm)
  • Patients presenting with chief complaint of respiratory distress/failure
  • Intranasal administration contradictions: nasal septal abnormalities, nasal trauma, epistaxis, excessive nasal mucus or blood, and intranasal damage, recent use of nasally administered vasoconstrictors such as cocaine, oxymetazoline, and phenylephrine

研究组 & 干预措施

Lorazepam

Active Comparator

干预措施: Lorazepam (Drug)

Haloperidol

Active Comparator

干预措施: Haloperidol (Drug)

IN Dex

Experimental

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Sedation

时间窗: Within one hour of administration

The primary outcome is to determine if intranasal dexmedetomidine is as effective in producing moderate sedation on the Modified Observer's Assessment of Alertness/Sedation Scale (MOAAS) as standard of care intravenous medications in older adults. The minimum value on the Modified Observer's Assessment of Alertness/Sedation Scale is 0 and the maximum value is 5. Lower scores mean a worse outcome.

次要结局

未报告次要终点

研究者

发起方
State University of New York - Upstate Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jay Brenner

Professor

State University of New York - Upstate Medical University

相似试验